February 9, 2016 : DCMS #279

DISASTERS AVERTED — Near Miss Case Studies

Create Safe Environment for Your Patients to Tell You the Truth

HOMERUN SLIDES — Great Clinical Presentation Highlights

Diabetes for Cardiologists Part 9

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #10: Epidemiology and Risk Factors for Type 1 Diabetes Mellitus Part 4 of 5

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Introducing Insulin Dosing Software

MOST POPULAR ARTICLES OF THE MONTH

#1 D2 – Dementia and Diabetes
#2 International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #9: Epidemiology and Risk Factors for Type 1 Diabetes Mellitus Part 3 of 5
#3 Transcript: Dr. Aaron Vinik Discusses the Shift in Diabetes Care

Our diabetes disaster looks at the idea that patients often don’t use the information they have to regulate their blood sugars, and a lot of times this is because the right information only makes things worse. Usually this has to do with insulin dosing, and for many patients it can have a detrimental effect.

One of the ways that we clinical professionals can help eliminate these kinds of events is to take advantage of software and programs. This week, we have an exclusive interview with Dr. Andy Rhinehart to learn about a new insulin dosing support software. This software is used in conjunction with doctor intervention and can likely help you avoid disasters.

Your partner in diabetes care,
Dave Joffe
Editor-in-chief

A teenage type 1 on an insulin pump was seen in our office for follow up. The download on her pump revealed some interesting numbers. First off, her glucose levels were out of target range and secondly her I:CHO ratio and her insulin sensitivity looked more like the numbers of a type 2 diabetic vs a type 1. Her I:CHO was 1:16 and her insulin sensitivity was 1:30. In my experience, I’m used to seeing a lower I:CHO and a higher insulin sensitivity in type 1 vs type 2.

In this week’s Homerun Slides, surprising information about SGLT-2 inhibitors.

Twin and family studies indicate that genetic factors alone cannot explain the etiology of T1DM. Seasonality, increasing incidence and epidemics of T1DM as well as numerous ecological, cross-sectional and retrospective studies suggest a critical role of environmental factors, such as infections with certain viruses (especially enteric infections in early life) and effects of early childhood diet. Natural history studies that follow children at increased risk of T1DM provide the best opportunity to study environmental triggers.

In part 1 of this Exclusive Interview, DIC Publisher Steve Freed talks with Dr. Andy Rhinehart to learn about a new insulin dosing support software that is used in conjunction with doctor intervention.

Uncontrolled blood glucose seems to increase the risk of brain troubles.

The first large-scale studies of the prediction of T1DM relied upon the detection of cytoplasmic islet cell autoantibodies (ICA) assays based on indirect immunofluorescence. High titer cytoplasmic ICA is most often associated with the presence of multiple islet autoantibodies and therefore a high risk of progression to diabetes.

In part 1 of this exclusive interview, DIC publisher Steve Freed talks with Dr. Aaron Vinik about the shift away from rigorous glycemic control in favor of greater focus on the impact of diabetes treatment on the heart.